Altre lingue Lumos Diagnostics Holdings Limited

Azioni

LDX

AU0000157091

Mercato chiuso - Australian S.E. Altri mercati azionari 08:10:44 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,055 ^AUD	-3,51%		-1,79%	-24,66%

09/04	Lo studio FebriDx di Lumos Diagnostics può aiutare a ottimizzare l'uso di antibiotici nei bambini con infezioni respiratorie febbrili.	MT
27/02	Lumos Diagnostics Holdings Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows	09/04
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%	12/02
Lumos Diagnostics' Q4 Revenue Jumps 55%	31/01
Australian Shares Rise Ahead of US Inflation Data	11/01
Lumos Diagnostics Signs Development and IP Agreements with Hologic; Shares Up 24%	11/01
Lumos Signs Major Development and IP Agreements with Hologic, Inc	10/01
Lumos Diagnostics Raises AU$2.7 Million to Support US Launch of FebriDx, ViraDx; Shares Down 6%	30/10/23
US FDA Grants Emergency Use Authorization for Lumos Diagnostics' ViraDx	11/09/23
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader	16/08/23
Lumos Diagnostics Expands FebriDx Market to Netherlands	16/08/23
Lumos Diagnostics Announces Core Camera Reader Patent Granted in Europe and Japan	16/08/23
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022	10/08/23
Lumos Diagnostics Signs Partnership with Henry Schein Medical for FebriDx Distribution; Shares Jump 8%	18/07/23
Lumos Diagnostics Holdings Limited Appoints Doug Ward to Board as Managing Director	13/07/23
Lumos Diagnostics Secures US FDA Clearance for Bacterial Respiratory Infection Test	03/07/23
Lumos Diagnostics Secures AU$9 Million in Funding from New Agreements With US Healthcare Company	16/03/23
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2022	26/02/23
Lumos Diagnostics Wins Two Service Agreements from Health Company Hologic	23/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lumos Diagnostics Holdings Limited

Azioni

LDX

AU0000157091

Altre lingue

Filtri